mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.09 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |